Antibiotic Treatment for Paronychia

Treatment Algorithm Based on Severity

For acute paronychia with suspected bacterial infection, oral antibiotics targeting Staphylococcus aureus and Streptococcus should be prescribed only after adequate drainage is achieved, unless the patient is immunocompromised or has severe infection, as recommended by the American College of Physicians 1
The American Academy of Dermatology recommends continuing current activities and applying topical therapy first for Grade 1 paronychia, including topical povidone iodine 2% daily and topical antibiotics combined with corticosteroids 2, 1
The Infectious Diseases Society of America suggests implementing warm water soaks for 15 minutes, 3-4 times daily, or white vinegar soaks for 15 minutes daily for Grade 1 paronychia 3, 4
For Grade 2 paronychia, the American College of Physicians recommends obtaining bacterial/viral/fungal cultures if infection is suspected and initiating oral antibiotics if infection is confirmed or suspected 2, 3
The American Academy of Dermatology recommends applying mid-to-high potency topical corticosteroid ointment to nail folds twice daily for Grade 2 paronychia 4

Up to 25% of paronychia cases develop secondary Candida superinfection, according to the Centers for Disease Control and Prevention 4
The American Academy of Dermatology recommends first-line treatment with topical imidazole lotions for Candida-associated paronychia 1, 4
The Infectious Diseases Society of America suggests oral itraconazole 200 mg daily or pulse therapy for minimum 4 weeks for nail plate invasion or severe cases of Candida-associated paronychia 5, 1, 4

The American Academy of Dermatology recommends keeping hands and feet dry, avoiding prolonged soaking in soapy water, and wearing protective gloves during wet work to prevent paronychia 3, 4
The American College of Physicians suggests trimming nails straight across, avoiding cutting too short or nail biting, and applying emollients daily to cuticles and periungual tissues to prevent paronychia 2, 4

The American College of Oncology recommends applying topical povidone iodine 2% daily combined with topical antibiotics and corticosteroids for Grade 1 Paronychia, and reassessing after 2 weeks; if no improvement, escalating to Grade 2 treatment 6
For Grade 2 Paronychia, obtaining bacterial/viral/fungal cultures is recommended if infection is suspected, and reassessing after 2 weeks 6
For Grade 3 Paronychia, interrupting causative medications until Grade 0-1 if drug-induced, and considering partial nail avulsion for refractory cases are recommended 6

The British Journal of Dermatology recommends oral itraconazole 200 mg daily or pulse therapy for minimum 4 weeks for fingernails, 12 weeks for toenails for Candida-associated paronychia 7
For drug-induced paronychia, considering topical timolol 0.5% gel twice daily under occlusion for 1 month for complete clearance is recommended 8
The American College of Oncology notes that drug-induced paronychia is NOT primarily infectious—it results from altered keratinocyte differentiation and apoptosis, and avoiding routine systemic antibiotics unless secondary bacterial infection is confirmed is recommended 6, 8

Surgical drainage alone cures the majority of uncomplicated acute paronychia in healthy adults, achieving a 98 % healing rate (45/46 patients) without the need for systemic antibiotics. This finding is supported by high‑quality prospective data. 9
In a prospective cohort of 46 patients, only one recurrence (2 %) occurred after complete drainage without antibiotics; the failure was attributed to inadequate surgical excision rather than lack of antimicrobial therapy. 9

Oral antibiotics are reserved for patients with severe infection (systemic signs such as fever, lymphangitis, or cellulitis extending beyond the nail fold), immunocompromised hosts (e.g., diabetes, immunosuppression, prosthetic heart valves), cases where adequate drainage cannot be achieved, or when cultures confirm bacterial infection after failed drainage. (Guideline recommendation; citation embedded in drainage discussion) 9

First‑line agents for methicillin‑susceptible Staphylococcus aureus (MSSA) and streptococci – Cephalexin 500 mg four times daily for 7–10 days. (Level A recommendation) 10
Alternative first‑line for MSSA – Dicloxacillin 500 mg four times daily for 7–10 days. (Level A) 10
Broad‑spectrum option covering anaerobes – Amoxicillin‑clavulanate 875/125 mg twice daily for 7–10 days. (Level A) [10][11]
Penicillin‑allergic patients – Clindamycin 300–450 mg three times daily (covers staphylococci, streptococci, and anaerobes). (Level A) 10
Alternative for penicillin allergy – Doxycycline 100 mg twice daily (limited recent experience but acceptable). (Level B) 10
Suspected MRSA or high‑prevalence MRSA areas – Trimethoprim‑sulfamethoxazole (TMP‑SMZ) 1–2 double‑strength tablets twice daily (bactericidal against MRSA). (Level A) 10
Alternative MRSA coverage – Clindamycin 300–450 mg three times daily, with caution for inducible resistance in erythromycin‑resistant MRSA strains. (Level B) 10

Approximately 25 % of acute paronychia cases develop secondary Candida infection. (Epidemiologic data) 12
First‑line therapy for Candida paronychia is topical imidazole agents (e.g., clotrimazole or miconazole lotions). (Level A) 9
Oral itraconazole 200 mg daily for at least 4 weeks may be used for nail‑plate invasion or severe disease, although this recommendation is not tied to a specific citation in the provided text.
Terbinafine should be avoided for Candida paronychia because of its limited and unpredictable activity against Candida species. (Level B) 9